A model for the return and referral of all clinically significant secondary findings of genomic sequencing

Abstract

Secondary findings (SFs) identified through genomic sequencing (GS) can offer a wide range of health benefits to patients. Resource and capacity constraints pose a challenge to their clinical management; therefore,...